0
Letters |

Rescreening of Cervical Papanicolaou Smears Using PAPNET—Reply

Timothy J. O'Leary, MD, PhD; Sally-Beth Buckner, SCT (ASCP); Curtis W. Ollayos, MD
JAMA. 1998;279(22):1785-1788. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-22-jac80008.
Text Size: A A A
Published online

Extract

In Reply.— Dr Greenberg suggests that the traditional Pap smear should be supplemented with HPV testing when ASCUS, AGUS, or LSIL is encountered. Since our study did not address HPV testing, we cannot address the cost-effectiveness of this strategy, but observe that routine Pap smear testing as infrequently as every 3 years can reduce the incidence of invasive cervical cancer by up to 90%.1

Dr Koss, Drs Mango and Radensky, and Dr Schechter would have preferred we perform a traditional cost-effectiveness analysis of PAPNET, rather than compare this relatively expensive rescreening strategy with the less expensive manual alternative. We wanted to find out how expensive it is to use PAPNET to find abnormal Pap smears that would be missed by manual rescreening. Cost-effectiveness analyses that ignore the existence of a less expensive alternative tend to make the proposed intervention look better than it really is; this is unquestionably the case with both the study by Schechter2 and the study by Radensky and Mango.3 These analyses are further limited by the use of pooled data3 and do not appear to address either interlaboratory variation or uncertainties in the rate of progression of premalignant lesions; these factors are considered more effectively by Raab.4

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs